1. Home
  2. TTRX vs KDK Comparison

TTRX vs KDK Comparison

Compare TTRX & KDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$10.09

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Logo Kodiak AI Inc.

KDK

Kodiak AI Inc.

N/A

Current Price

$1.16

Market Cap

335.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TTRX
KDK
Founded
2015
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
298.8M
335.0M
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
TTRX
KDK
Price
$10.09
$1.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
★ $25.00
$9.67
AVG Volume (30 Days)
83.7K
★ 6.3M
Earning Date
11-25-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,797,000.00
Revenue This Year
N/A
$181.17
Revenue Next Year
$900.00
$208.63
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.57
$0.96
52 Week High
$16.45
$11.35

Technical Indicators

Market Signals
Indicator
TTRX
KDK
Relative Strength Index (RSI) 42.31 29.05
Support Level $10.05 $0.96
Resistance Level $10.72 $1.85
Average True Range (ATR) 0.78 0.13
MACD -0.02 0.07
Stochastic Oscillator 29.98 30.14

Price Performance

Historical Comparison
TTRX
KDK

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

About KDK Kodiak AI Inc.

Kodiak AI Inc is a provider of artificial intelligence (AI)-powered autonomous vehicle technology. This technology addresses the needs of the long-haul trucking, industrial trucking, and defense industries. The company's core offering, the Kodiak Driver, is a single-platform virtual driver that combines advanced AI software with modular hardware for customer deployments. All company operations are conducted in the United States. The company has one operating and reportable segment related to the development of autonomous vehicle technology and related services that can be applied at scale across a broad range of industries and environments.

Share on Social Networks: